Biotech Values

[DewDiligence]

Orthopedics are more discretionary than most kinds of healthcare. That’s why such formerly high-flying orthopedics companies as ZMH are issuing tepid guidance for 2009:

http://finance.yahoo.com/news/Zimmer-Reports-Fourth-Quarter-prnews-14191897.html

The Company expects full-year revenues for 2009 to increase between 1% and 3% on a constant currency basis, with revenues anticipated to be flat in the first half of the year and improving thereafter.

This is quite a comedown from the bullish expectations seven months ago (#msg-30016787) and the even more bullish projections made a few years ago (#msg-2351794).